Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore F Reiss

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Chest|June 19, 2007
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstrictionGeorge Philip, David S Pearlman, César Villarán, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 13, 2010
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthmaGeorge Philip, Andrew Pedinoff, Kristel Vandormael, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2009
Analysis of behavior-related adverse experiences in clinical trials of montelukastGeorge Philip, Carolyn M Hustad, Marie-Pierre Malice, et al.
Current Medical Research and Opinion|October 7, 2004
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitisGeorge Philip, Anjuli S Nayak, William E Berger, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2009
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitisGeorge Philip, Janet van Adelsberg, Thomas Loeys, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 27, 2003
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitisJanet van Adelsberg, George Philip, Craig F LaForce, et al.
Journal of Clinical Pharmacology|February 26, 2008
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitisGregory L Kearns, Susan Lu, Lata Maganti, et al.
Respiratory Medicine|October 26, 2010
MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary diseaseJonathan A Bernstein, Nancy Liu, Barbara A Knorr, et al.
Pediatric Pulmonology|May 19, 2009
Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensionsHans Bisgaard, David Skoner, Maria L Boza, et al.
Pediatric Pulmonology|July 31, 2007
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic childrenSøren Pedersen, Lone Agertoft, Debora Williams-Herman, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Chest|June 19, 2007
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstrictionGeorge Philip, David S Pearlman, César Villarán, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 13, 2010
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthmaGeorge Philip, Andrew Pedinoff, Kristel Vandormael, et al.
The Journal of Allergy and Clinical Immunology|October 10, 2009
Analysis of behavior-related adverse experiences in clinical trials of montelukastGeorge Philip, Carolyn M Hustad, Marie-Pierre Malice, et al.
Current Medical Research and Opinion|October 7, 2004
The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitisGeorge Philip, Anjuli S Nayak, William E Berger, et al.
The Journal of Allergy and Clinical Immunology|September 15, 2009
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitisGeorge Philip, Janet van Adelsberg, Thomas Loeys, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 27, 2003
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitisJanet van Adelsberg, George Philip, Craig F LaForce, et al.
Journal of Clinical Pharmacology|February 26, 2008
Pharmacokinetics and safety of montelukast oral granules in children 1 to 3 months of age with bronchiolitisGregory L Kearns, Susan Lu, Lata Maganti, et al.
Respiratory Medicine|October 26, 2010
MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary diseaseJonathan A Bernstein, Nancy Liu, Barbara A Knorr, et al.
Pediatric Pulmonology|May 19, 2009
Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensionsHans Bisgaard, David Skoner, Maria L Boza, et al.
Pediatric Pulmonology|July 31, 2007
Placebo-controlled study of montelukast and budesonide on short-term growth in prepubertal asthmatic childrenSøren Pedersen, Lone Agertoft, Debora Williams-Herman, et al.
Pageof 6